Literature DB >> 12530995

Agrypnia excitata: clinical features and pathophysiological implications.

Elio Lugaresi1, Federica Provini.   

Abstract

Fatal familial insomnia, Morvan's chorea and delirium tremens share the same clinical features: severe insomnia and mental confusion with dream enactment, associated with motor and autonomic activation. Polygraphically, they share an inability to generate slow wave sleep. Agrypnia excitata is the term which aptly defines this peculiar medical condition. In fatal familial insomnia, the syndrome is due to a functional imbalance between activating and deactivating structures within the limbic system provoked by the atrophy of the mediodorsal and anteroventral thalamic nuclei. In Morvan's chorea and delirium tremens, a functional imbalance within the thalamolimbic circuits might be explained by the accumulation of some antireceptor antibodies and by a transient prevalence of excitatory over inhibitory synapses, down-regulated by chronic alcohol abuse, respectively. The selective disappearance of slow sleep (i.e. sleep spindles and delta rhythms) characterizing the agrypnia excitata syndrome, together with other clinical and experimental findings, suggests that sleep can be divided into three types. The most archaic form of sleep corresponding to stage 1 non-REM sleep is shared by man and poikilothermic animals and generated within activating and deactivating neuronal poles located in the basal forebrain, hypothalamus and brain stem; the other two forms of sleep, slow wave sleep and paradoxical sleep, confined to homeothermic animals, are generated in the thalamus and pontine reticular formation respectively. 2001 Harcourt Publishers Ltd

Entities:  

Year:  2001        PMID: 12530995     DOI: 10.1053/smrv.2001.0166

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  12 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations.

Authors:  Franc Llorens; Juan-José Zarranz; Andre Fischer; Inga Zerr; Isidro Ferrer
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

Review 3.  Sleep and neurological autoimmune diseases.

Authors:  Alex Iranzo
Journal:  Neuropsychopharmacology       Date:  2019-07-14       Impact factor: 7.853

Review 4.  Agrypnia excitata.

Authors:  Federica Provini
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

5.  Visual hallucinations and pontine demyelination in a child: possible REM dissociation?

Authors:  Maria Gabriella Vita; Anna Paola Batocchi; Serena Dittoni; Anna Losurdo; Alessandro Cianfoni; Maria Chiara Stefanini; Catello Vollono; Giacomo Della Marca; Paolo Mariotti
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

Review 6.  A review of drug therapy for sporadic fatal insomnia.

Authors:  Pardis Tabaee Damavandi; Martin T Dove; Richard W Pickersgill
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

Review 7.  Review of rapid eye movement behavior sleep disorders.

Authors:  Vivien C Abad; Christian Guilleminault
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

Review 8.  Sleep Disturbances in Patients with Autoimmune Encephalitis.

Authors:  Margaret S Blattner; Gregory S Day
Journal:  Curr Neurol Neurosci Rep       Date:  2020-06-10       Impact factor: 5.081

Review 9.  The eleventh reported case of Mulvihill-Smith syndrome in the literature.

Authors:  Paulo Breinis; Flavio Geraldes Alves; Camila A E Alves; Rafael G Cintra; Débora Almeida; Priscila C Passarelli; Camila Domingues; Talita Gerbim; Régia Gasparetto; Luiz Carlos de Abreu; Vitor E Valenti; Adriana Gonçalves de Oliveira; Carlos Bandeira de Mello Monteiro; Rubens Wajnzstejn
Journal:  BMC Neurol       Date:  2014-01-07       Impact factor: 2.474

10.  Sleep disorder, chorea, and dementia associated with IgLON5 antibodies.

Authors:  Mateus M Simabukuro; Lidia Sabater; Tarso Adoni; Rubens Gisbert Cury; Mônica Santoro Haddad; Camila Hobi Moreira; Luana Oliveira; Mateus Boaventura; Rosana Cardoso Alves; Leticia Azevedo Soster; Ricardo Nitrini; Carles Gaig; Joan Santamaria; Josep Dalmau; Francesc Graus
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.